Description
LPL Antibody | 23-817 | Gentaur UK, US & Europe Distribution
Host: Rabbit
Reactivity: Human
Homology: N/A
Immunogen: A synthetic peptide of human LPL
Research Area: Cancer, Neuroscience, Obesity, Signal Transduction, Stem Cell
Tested Application: WB, IHC, Flow
Application: WB: 1:200 - 1:1000
IHC: 1:20 - 1:200
Flow: 1:20 - 1:50
Specificiy: N/A
Positive Control 1: HepG2
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: Observed: 53kDa
Validation: N/A
Isoform: N/A
Purification: Affinity purification
Clonality: Polyclonal
Clone: N/A
Isotype: IgG
Conjugate: Unconjugated
Physical State: Liquid
Buffer: PBS with 0.02% sodium azide, pH7.3.
Concentration: N/A
Storage Condition: Store at 4˚C. Avoid freeze / thaw cycles.
Alternate Name: Lipoprotein lipase, LPL, LPL, LIPD
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.